IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 192 filers reported holding IMMUNITYBIO INC in Q2 2024. The put-call ratio across all filers is 2.89 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $828 | +24.1% | 130,761 | +5.6% | 0.00% | – |
| Q1 2024 | $667 | +11.0% | 123,879 | +3.8% | 0.00% | – |
| Q4 2023 | $601 | +221.4% | 119,346 | +8.0% | 0.00% | – |
| Q3 2023 | $187 | -53.0% | 110,512 | -22.5% | 0.00% | – |
| Q2 2023 | $398 | +30.9% | 142,540 | -14.5% | 0.00% | – |
| Q1 2023 | $304 | -60.0% | 166,758 | +11.2% | 0.00% | – |
| Q4 2022 | $760 | -99.9% | 149,958 | -5.0% | 0.00% | – |
| Q3 2022 | $785,000 | +43.8% | 157,866 | +7.6% | 0.00% | – |
| Q2 2022 | $546,000 | -41.0% | 146,717 | -11.1% | 0.00% | – |
| Q1 2022 | $926,000 | -20.4% | 165,121 | -13.7% | 0.00% | – |
| Q4 2021 | $1,164,000 | -34.4% | 191,402 | +5.1% | 0.00% | – |
| Q3 2021 | $1,774,000 | -42.2% | 182,102 | -15.3% | 0.00% | – |
| Q2 2021 | $3,070,000 | -36.3% | 215,008 | +5.9% | 0.00% | – |
| Q1 2021 | $4,818,000 | – | 202,938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 335,709 | $2,121,681 | 1.13% |
| Accurate Wealth Management, LLC | 560,000 | $3,561,600 | 0.85% |
| ALLEN HOLDING INC /NY | 687,571 | $4,345,449 | 0.54% |
| SHEETS SMITH WEALTH MANAGEMENT | 665,995 | $4,209,088 | 0.50% |
| Cormorant Asset Management, LP | 1,250,000 | $7,900,000 | 0.46% |
| Clearwater Capital Advisors, LLC | 482,549 | $3,049,710 | 0.32% |
| WEALTH EFFECTS LLC | 87,500 | $553,000 | 0.20% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $609,457 | 0.19% |
| Virtus ETF Advisers LLC | 56,107 | $354,596 | 0.17% |
| COLLECTIVE FAMILY OFFICE LLC | 70,355 | $444,644 | 0.13% |